 | • レポートコード：MRC2211A037 • 出版社/出版日：Persistence Market Research / 2022年9月 • レポート形態：英文、PDF、250ページ • 納品方法：Eメール • 産業分類：医療 |
| Single User | ￥725,200 (USD4,900) | ▷ お問い合わせ |
| Site Licence | ￥1,124,800 (USD7,600) | ▷ お問い合わせ |
| Enterprisewide | ￥1,568,800 (USD10,600) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| Persistence Market Research社の本調査レポートは、世界の感染症検査における分子診断市場について調査し、エグゼクティブサマリー、市場概要、主要市場動向、規則・規制、需要分析・予測、価格分析、市場背景、製品別（測定器・分析器、アッセイ・試薬、サービス・ソフトウェア）分析、用途別（B型肝炎、C型肝炎、エイズ、結核、メチシリン耐性黄色ブドウ球菌（MRSA））分析、技術別（ポリメラーゼ連鎖反応（PCR）、等温核酸増幅法（INAAT）、マイクロアレイ、次世代シーケンサー（NGS）、ハイブリダイゼーション、その他）分析、エンドユーザー別（病院、民間研究所、診療所、学術機関、研究室）分析、地域別（北米、中南米、ヨーロッパ、南アジア太平洋、東アジア、中東/アフリカ）分析、仮定、調査手法などを整理しております。本書では、Abbott Laboratories、Becton、Dickinson and Company、bioMérieux、Thermo Fisher Scientific Inc.、F. Hoffmann-La Roche Ltd、Siemens AG、Veridex, LLC、Luminex Corp.、GenMark Diagnostics, Inc.、Qiagen N.V.などの企業情報が含まれています。 ・エグゼクティブサマリー ・市場概要 ・主要市場動向 ・規則・規制 ・需要分析・予測 ・価格分析 ・市場背景 ・世界の感染症検査における分子診断市場規模：製品別 - 測定器・分析器の市場規模 - アッセイ・試薬の市場規模 - サービス・ソフトウェアの市場規模 ・世界の感染症検査における分子診断市場規模：用途別 - B型肝炎における市場規模 - C型肝炎における市場規模 - エイズにおける市場規模 - 結核における市場規模 - メチシリン耐性黄色ブドウ球菌（MRSA）における市場規模 ・世界の感染症検査における分子診断市場規模：技術別 - ポリメラーゼ連鎖反応（PCR）の市場規模 - 等温核酸増幅法（INAAT）の市場規模 - マイクロアレイの市場規模 - 次世代シーケンサー（NGS）の市場規模 - ハイブリダイゼーションの市場規模 ・世界の感染症検査における分子診断市場規模：エンドユーザー別 - 病院における市場規模 - 民間研究所における市場規模 - 診療所における市場規模 - 学術機関における市場規模 - 研究室における市場規模 ・世界の感染症検査における分子診断市場規模：地域別 - 北米の感染症検査における分子診断市場規模 - 中南米の感染症検査における分子診断市場規模 - ヨーロッパの感染症検査における分子診断市場規模 - 南アジア太平洋の感染症検査における分子診断市場規模 - 東アジアの感染症検査における分子診断市場規模 - 中東/アフリカの感染症検査における分子診断市場規模 ・仮定 ・調査手法 |
Molecular Diagnostics in Infectious Disease Testing Market – Scope of Report
Persistence Market Research recently published a new report on the molecular diagnostics in infectious disease testing market for the assessment period of 2022-2032. The report offers a close look at the evolving aspects of the market, and insights into the dynamics impacting market growth. It also focuses on key developments in the market, especially due to the COVID-19 pandemic situation that has affected people, globally. The report includes various macro- and micro-economic factors responsible for a significant impact on market growth.
The report on the molecular diagnostics in infectious disease testing market extensively focuses on the key trends shaping its growth. Additionally, the included opportunity analysis underlines untapped corners for aspiring players. The report also offers a holistic view of the incremental opportunity, which can further help readers make effective decisions for the growth of their businesses.
All stakeholders in the molecular diagnostics in infectious disease testing market can rely on the data offered in this report to make critical decisions. Moreover, the information offered in this report also can help new market entrants expand their bases in this space.
The report elaborates on both, historical and current trends shaping the molecular diagnostics in infectious disease testing market. The performance journey of the market has been drawn and analyzed to make the lucrative opportunities in the market evident to readers. The competitive landscape presented in the report gives a detailed outlook of the profiles of key companies manufacturing molecular diagnostics in infectious disease testing, along with their differential strategies and key focus areas.
Segmentation
The research study offers a detailed market taxonomy, wherein, key segments have been discussed in detail. The market is segmented on the basis of product, application, technique, end user, and region. Every segment is analyzed in detail, and data pertaining to the growth of each segment has been included in the study.
Product
Instruments and Analyzers
Assays and Reagents
Services and Software
Application
Hepatitis B
Hepatitis C
AIDS
Tuberculosis
Methicillin-Resistant Staphylococcus Aureus (MRSA)
Hospital-Acquired Infections
Chlamydia Trachomatis and Neisseria Gonorrhoeae (CT/NG)
Human Papillomavirus (HPV) Infection
Others
Technique
Polymerase Chain Reaction (PCR)
Isothermal Nucleic Acid Amplification Technology (INAAT)
Microarrays
Next-Generation Sequencing (NGS)
Hybridization
Others
End User
Hospitals
Private Labs
Clinics
Academic Institutes
Laboratories
Others
Region
North America
Latin America
Europe
East Asia
South Asia
Oceania
Middle East & Africa
The research report includes a competitive landscape that provides a dashboard view of the key competitors operating in the market. Some of the market players included in this section are Abbott Laboratories, Becton, Dickinson and Company, bioMérieux, Thermo Fisher Scientific Inc., F. Hoffmann-La Roche Ltd, Siemens AG, Veridex, LLC, Luminex Corp., GenMark Diagnostics, Inc., Qiagen N.V., Genomix Biotech, and bioTheranostics.
Key Questions Answered in Report
The research study on the manufacturing molecular diagnostics in infectious disease testing market offers inclusive insights about the growth of the market in the most comprehensive manner. Key insights offered in the report answer some of the most salient questions that assist stakeholders in gauging all the emerging possibilities.
Will the polymerase chain reaction (PCR) segment continue driving the sales of molecular diagnostics in infectious disease testing market?
How are technological developments aiding molecular diagnostics in infectious disease testing market?
Which region is a key contributor to the global molecular diagnostics in infectious disease testing market?
Research Methodology
A unique and promising research methodology forms the base of the market report for the forecast period. This report has been prepared after comprehensive analysis of market events, and riveting insights have been compiled meticulously.
The research methodology is a two-step process comprising primary and secondary research. Key stakeholders, including suppliers, service providers, and experts of several designations, including executive vice presidents, directors, technical advisors, GM marketing professionals, and sales professionals have been interviewed. Secondary sources referred to obtain information include investor presentations of manufacturers, World Bank, IMF, and other credible sources.
レポート目次1. Executive Summary
1.1. Global Market Overview
1.2. Summary of Key Statistics
1.3. Summary of Key Findings
1.4. Product Evolution Analysis
1.5. PMR Analysis and Recommendations
2. Market Overview
2.1. Market Coverage/Taxonomy
2.2. Market Definition/Scope/Limitations
3. Key Market Trends
3.1. Key Trends Impacting the Market
3.2. Future Prospects of Molecular Diagnostics in Infectious Disease Testing Industry
3.2.1. Factors Fuelling Growth
3.2.2. Influx of Brands
3.2.3. Innovative Distribution & Marketing Strategies
4. Rules and Regulations
4.1. Warning Labels
4.2. Regulatory Options for Little Cigars
4.2.1. Product Description
4.2.2. Health Risks
4.2.3. End Usering
4.2.4. Minimum Pack Technique Regulatory Gap
4.3. Cigar Labeling and Warning Statement Requirements by FDA
4.4. Tobacco Control Laws
4.4.1. Use of E-Cigarettes is Prohibited
4.4.2. Tobacco Advertising is Prohibited in Mass Media
4.4.3. Others
4.5. Others (During the Course of Study)
5. Global Molecular Diagnostics in Infectious Disease Testing Market Demand Analysis 2017-2021 and Forecast, 2022-2032
5.1. Historical Market Volume (‘000 Units) Analysis, 2017-2021
5.2. Current and Future Market Volume (‘000 Units) Projections, 2022-2032
5.3. Y-o-Y Growth Trend Analysis
6. Global Molecular Diagnostics in Infectious Disease Testing Market – Pricing Analysis
6.1. Pricing Analysis By Product
6.2. Global Average Pricing Analysis Benchmark
7. Global Molecular Diagnostics in Infectious Disease Testing Market Demand (in Value or Technique in US$ Mn) Analysis 2017-2021 and Forecast, 2022-2032
7.1. Historical Market Value (US$ Mn) Analysis, 2017-2021
7.2. Current and Future Market Value (US$ Mn) Projections, 2022-2032
7.2.1. Y-o-Y Growth Trend Analysis
7.2.2. Absolute $ Opportunity Analysis
8. Market Background
8.1. Global Cigar industry Outlook
8.1.1. Perception of Cigars
8.1.2. Prevalence of Smoking Cigars among Adults
8.1.3. Top 10 Cigars & Cigarillo Companies in the World
8.2. Macro-Economic Factors
8.2.1. GDP Growth Outlook
8.2.2. Consumer Spending Outlook
8.2.3. GDP Growth Rate Analysis
8.2.4. Income Group Population Overview
8.2.5. Per Capita Disposable Income
8.3. Forecast Factors – Relevance & Impact
8.3.1. Top Companies Historical Growth
8.3.2. Urbanization Growth Outlook
8.3.3. Others
8.4. PESTLE Analysis of Global Molecular Diagnostics in Infectious Disease Testing Market
8.5. Investment Feasibility Matrix of Molecular Diagnostics in Infectious Disease Testing Market
8.6. Porter’s Five Forces Analysis of Global Molecular Diagnostics in Infectious Disease Testing Market
8.7. Market Dynamics
8.7.1. Drivers
8.7.2. Restraints
8.7.3. Opportunity Analysis
9. Global Molecular Diagnostics in Infectious Disease Testing Market Analysis 2017-2021 and Forecast 2022-2032, By Product
9.1. Introduction / Key Findings
9.2. Historical Market Size (US$ Mn) and Volume (‘000 Units) Analysis by Product, 2017 – 2021
9.3. Current and Future Market Size (US$ Mn) and Volume (‘000 Units) Analysis and Forecast by Product, 2022 – 2032
9.3.1. Instruments and Analyzers
9.3.2. Assays and Reagents
9.3.3. Services and Software
9.4. Market Attractiveness Analysis by Product
10. Global Molecular Diagnostics in Infectious Disease Testing Market Analysis 2017-2021 and Forecast 2022-2032, by Application
10.1. Introduction / Key Findings
10.2. Historical Market Size (US$ Mn) and Volume (‘000 Units) Analysis by Application, 2017 – 2021
10.3. Current and Future Market Size (US$ Mn) and Volume (‘000 Units) Analysis and Forecast by Application, 2022 – 2032
10.3.1. Hepatitis B
10.3.2. Hepatitis C
10.3.3. AIDS
10.3.4. Tuberculosis
10.3.5. Methicillin-Resistant Staphylococcus Aureus (MRSA)
10.3.6. Hospital-Acquired Infections
10.3.7. Chlamydia Trachomatis and Neisseria Gonorrhoeae (CT/NG)
10.3.8. Human Papillomavirus (HPV) Infection
10.3.9. Others
10.4. Market Attractiveness Analysis by Application
11. Global Molecular Diagnostics in Infectious Disease Testing Market Analysis 2017-2021 and Forecast 2022-2032, by Technique
11.1. Introduction / Key Findings
11.2. Historical Market Size (US$ Mn) and Volume (‘000 Units) Analysis by Technique, 2017 – 2021
11.3. Current and Future Market Size (US$ Mn) and Volume (‘000 Units) Analysis and Forecast by Technique, 2022 – 2032
11.3.1. Polymerase Chain Reaction (PCR)
11.3.2. Isothermal Nucleic Acid Amplification Technology (INAAT)
11.3.3. Microarrays
11.3.4. Next-Generation Sequencing (NGS)
11.3.5. Hybridization
11.3.6. Others
11.4. Market Attractiveness Analysis by Technique
12. Global Molecular Diagnostics in Infectious Disease Testing Market Analysis 2017-2021 and Forecast 2022-2032, by End User
12.1. Introduction / Key Findings
12.2. Historical Market Size (US$ Mn) and Volume (‘000 Units) Analysis by Flavor, 2017 – 2021
12.3. Current and Future Market Size (US$ Mn) and Volume (‘000 Units) Analysis and Forecast by Flavor, 2022 – 2032
12.3.1. Hospitals
12.3.2. Private Labs
12.3.3. Clinics
12.3.4. Academic Institutes
12.3.5. Laboratories
12.3.6. Others
12.4. Market Attractiveness Analysis by Flavor
13. Global Molecular Diagnostics in Infectious Disease Testing Market Analysis 2017-2021 and Forecast 2022-2032, by Region
13.1. Introduction
13.2. Historical Market Size (US$ Mn) and Volume (‘000 Units) Analysis by Region, 2017 – 2021
13.3. Current Market Size (US$ Mn) and Volume (‘000 Units) Analysis and Forecast by Region, 2022 – 2032
13.3.1. North America
13.3.2. Latin America
13.3.3. Europe
13.3.4. East Asia
13.3.5. South Asia
13.3.6. Oceania
13.3.7. Middle East and Africa (MEA)
13.4. Market Attractiveness Analysis by Region
14. North America Molecular Diagnostics in Infectious Disease Testing Market Analysis 2017-2021 and Forecast 2022-2032
14.1. Introduction
14.2. Pricing Analysis
14.3. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2017 – 2021
14.4. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2022 – 2032
14.4.1. By Country
14.4.1.1. U.S.
14.4.1.2. Canada
14.4.2. By Product
14.4.3. By End User
14.4.4. By Application
14.4.5. By Technique
14.5. Market Attractiveness Analysis
14.5.1. By Country
14.5.2. By Product
14.5.3. By End User
14.5.4. By Application
14.5.5. By Technique
15. Latin America Molecular Diagnostics in Infectious Disease Testing Market Analysis 2017-2021 and Forecast 2022-2032
15.1. Introduction
15.2. Pricing Analysis
15.3. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2017 – 2021
15.4. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2022 – 2032
15.4.1. By Country
15.4.1.1. Brazil
15.4.1.2. Mexico
15.4.1.3. Rest of Latin America
15.4.2. By Product
15.4.3. By End User
15.4.4. By Application
15.4.5. By Technique
15.5. Market Attractiveness Analysis
15.5.1. By Country
15.5.2. By Product
15.5.3. By End User
15.5.4. By Application
15.5.5. By Technique
16. Europe Molecular Diagnostics in Infectious Disease Testing Market Analysis 2017-2021 and Forecast 2022-2032
16.1. Introduction
16.2. Pricing Analysis
16.3. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2017 – 2021
16.4. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2022 – 2032
16.4.1. By Country
16.4.1.1. Germany
16.4.1.2. Italy
16.4.1.3. France
16.4.1.4. U.K.
16.4.1.5. Spain
16.4.1.6. Rest of Europe
16.4.2. By Product
16.4.3. By End User
16.4.4. By Application
16.4.5. By Technique
16.5. Market Attractiveness Analysis
16.5.1. By Country
16.5.2. By Product
16.5.3. By End User
16.5.4. By Application
16.5.5. By Technique
17. South Asia Molecular Diagnostics in Infectious Disease Testing Market Analysis 2017-2021 and Forecast 2022-2032
17.1. Introduction
17.2. Pricing Analysis
17.3. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2017 – 2021
17.4. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2022 – 2032
17.4.1. By Country
17.4.1.1. India
17.4.1.2. Thailand
17.4.1.3. Indonesia
17.4.1.4. Malaysia
17.4.1.5. Rest of South Asia
17.4.2. By Product
17.4.3. By End User
17.4.4. By Application
17.4.5. By Technique
17.5. Market Attractiveness Analysis
17.5.1. By Country
17.5.2. By Product
17.5.3. By End User
17.5.4. By Application
17.5.5. By Technique
18. East Asia Molecular Diagnostics in Infectious Disease Testing Market Analysis 2017-2021 and Forecast 2022-2032
18.1. Introduction
18.2. Pricing Analysis
18.3. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2017 – 2021
18.4. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2022 – 2032
18.4.1. By Country
18.4.1.1. China
18.4.1.2. Japan
18.4.1.3. South Korea
18.4.2. By Product
18.4.3. By End User
18.4.4. By Application
18.4.5. By Technique
18.5. Market Attractiveness Analysis
18.5.1. By Country
18.5.2. By Product
18.5.3. By End User
18.5.4. By Application
18.5.5. By Technique
19. Oceania Molecular Diagnostics in Infectious Disease Testing Market Analysis 2017-2021 and Forecast 2022-2032
19.1. Introduction
19.2. Pricing Analysis
19.3. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2017 – 2021
19.4. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2022 – 2032
19.4.1. By Country
19.4.1.1. Australia
19.4.1.2. New Zealand
19.4.2. By Product
19.4.3. By End User
19.4.4. By Application
19.4.5. By Technique
19.5. Market Attractiveness Analysis
19.5.1. By Country
19.5.2. By Product
19.5.3. By End User
19.5.4. By Application
19.5.5. By Technique
20. Middle East and Africa Molecular Diagnostics in Infectious Disease Testing Market Analysis 2017-2021 and Forecast 2022-2032
20.1. Introduction
20.2. Pricing Analysis
20.3. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2017 – 2021
20.4. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2022 – 2032
20.4.1. By Country
20.4.1.1. GCC Countries
20.4.1.2. Northern Africa
20.4.1.3. South Africa
20.4.1.4. Rest of Middle East and Africa
20.4.2. By Product
20.4.3. By End User
20.4.4. By Application
20.4.5. By Technique
20.5. Market Attractiveness Analysis
20.5.1. By Country
20.5.2. By Product
20.5.3. By End User
20.5.4. By Application
20.5.5. By Technique
21. Key Countries’ Molecular Diagnostics in Infectious Disease Testing Market Analysis 2022-2032
21.1. Introduction
21.1.1. Market Value Proportion Analysis, By Key Countries
21.1.2. Global Vs. Country Growth Comparison
21.2. U.S. Molecular Diagnostics in Infectious Disease Testing Market Analysis
21.2.1. By Product
21.2.2. By End User
21.2.3. By Application
21.2.4. By Technique
21.3. Canada Molecular Diagnostics in Infectious Disease Testing Market Analysis
21.3.1. By Product
21.3.2. By End User
21.3.3. By Application
21.3.4. By Technique
21.4. Mexico Molecular Diagnostics in Infectious Disease Testing Market Analysis
21.4.1. By Product
21.4.2. By End User
21.4.3. By Application
21.4.4. By Technique
21.5. Brazil Molecular Diagnostics in Infectious Disease Testing Market Analysis
21.5.1. By Product
21.5.2. By End User
21.5.3. By Application
21.5.4. By Technique
21.6. Germany Molecular Diagnostics in Infectious Disease Testing Market Analysis
21.6.1. By Product
21.6.2. By End User
21.6.3. By Application
21.6.4. By Technique
21.7. Italy Molecular Diagnostics in Infectious Disease Testing Market Analysis
21.7.1. By Product
21.7.2. By End User
21.7.3. By Application
21.7.4. By Technique
21.8. U.K. Molecular Diagnostics in Infectious Disease Testing Market Analysis
21.8.1. By Product
21.8.2. By End User
21.8.3. By Application
21.8.4. By Technique
21.9. China Molecular Diagnostics in Infectious Disease Testing Market Analysis
21.9.1. By Product
21.9.2. By End User
21.9.3. By Application
21.9.4. By Technique
21.10. Japan Molecular Diagnostics in Infectious Disease Testing Market Analysis
21.10.1. By Product
21.10.2. By End User
21.10.3. By Application
21.10.4. By Technique
21.11. S. Korea Molecular Diagnostics in Infectious Disease Testing Market Analysis
21.11.1. By Product
21.11.2. By End User
21.11.3. By Application
21.11.4. By Technique
21.12. India Molecular Diagnostics in Infectious Disease Testing Market Analysis
21.12.1. By Product
21.12.2. By End User
21.12.3. By Application
21.12.4. By Technique
21.13. Australia and New Zealand Molecular Diagnostics in Infectious Disease Testing Market Analysis
21.13.1. By Product
21.13.2. By End User
21.13.3. By Application
21.13.4. By Technique
21.14. South Africa Molecular Diagnostics in Infectious Disease Testing Market Analysis
21.14.1. By Product
21.14.2. By End User
21.14.3. By Application
21.14.4. By Technique
22. Market Structure Analysis
22.1. Market Analysis by Tier of Companies (Molecular Diagnostics in Infectious Disease Testing)
22.2. Market Concentration
22.3. Market Share Analysis of Top Players
22.4. Market Presence Analysis
22.4.1. By Regional footprint of Players
22.4.2. Product foot print by Players
22.4.3. Channel Foot Print by Players
23. Competition Analysis
23.1. Competition Dashboard
23.2. Pricing Analysis by Competition
23.3. Competition Benchmarking
23.4. Competition Deep Dive
23.4.1. Abbott Laboratories
23.4.1.1. Overview
23.4.1.2. Product Portfolio
23.4.1.3. Profitability by Market Segments (Product/Channel/Region)
23.4.1.4. Sales Footprint
23.4.1.5. Strategy Overview
23.4.1.5.1. Marketing Strategy
23.4.1.5.2. Product Strategy
23.4.1.5.3. Channel Strategy
23.4.2. Becton
23.4.2.1. Overview
23.4.2.2. Product Portfolio
23.4.2.3. Profitability by Market Segments (Product/Channel/Region)
23.4.2.4. Sales Footprint
23.4.2.5. Strategy Overview
23.4.2.5.1. Marketing Strategy
23.4.2.5.2. Product Strategy
23.4.2.5.3. Channel Strategy
23.4.3. Dickinson and Company
23.4.3.1. Overview
23.4.3.2. Product Portfolio
23.4.3.3. Profitability by Market Segments (Product/Channel/Region)
23.4.3.4. Sales Footprint
23.4.3.5. Strategy Overview
23.4.3.5.1. Marketing Strategy
23.4.3.5.2. Product Strategy
23.4.3.5.3. Channel Strategy
23.4.4. bioMérieux
23.4.4.1. Overview
23.4.4.2. Product Portfolio
23.4.4.3. Profitability by Market Segments (Product/Channel/Region)
23.4.4.4. Sales Footprint
23.4.4.5. Strategy Overview
23.4.4.5.1. Marketing Strategy
23.4.4.5.2. Product Strategy
23.4.4.5.3. Channel Strategy
23.4.5. Thermo Fisher Scientific Inc.
23.4.5.1. Overview
23.4.5.2. Product Portfolio
23.4.5.3. Profitability by Market Segments (Product/Channel/Region)
23.4.5.4. Sales Footprint
23.4.5.5. Strategy Overview
23.4.5.5.1. Marketing Strategy
23.4.5.5.2. Product Strategy
23.4.5.5.3. Channel Strategy
23.4.6. F. Hoffmann-La Roche Ltd
23.4.6.1. Overview
23.4.6.2. Product Portfolio
23.4.6.3. Profitability by Market Segments (Product/Channel/Region)
23.4.6.4. Sales Footprint
23.4.6.5. Strategy Overview
23.4.6.5.1. Marketing Strategy
23.4.6.5.2. Product Strategy
23.4.6.5.3. Channel Strategy
23.4.7. Siemens AG
23.4.7.1. Overview
23.4.7.2. Product Portfolio
23.4.7.3. Profitability by Market Segments (Product/Channel/Region)
23.4.7.4. Sales Footprint
23.4.7.5. Strategy Overview
23.4.7.5.1. Marketing Strategy
23.4.7.5.2. Product Strategy
23.4.7.5.3. Channel Strategy
23.4.8. Veridex, LLC
23.4.8.1. Overview
23.4.8.2. Product Portfolio
23.4.8.3. Profitability by Market Segments (Product/Channel/Region)
23.4.8.4. Sales Footprint
23.4.8.5. Strategy Overview
23.4.8.5.1. Marketing Strategy
23.4.8.5.2. Product Strategy
23.4.8.5.3. Channel Strategy
23.4.9. Luminex Corp.
23.4.9.1. Overview
23.4.9.2. Product Portfolio
23.4.9.3. Profitability by Market Segments (Product/Channel/Region)
23.4.9.4. Sales Footprint
23.4.9.5. Strategy Overview
23.4.9.5.1. Marketing Strategy
23.4.9.5.2. Product Strategy
23.4.9.5.3. Channel Strategy
23.4.10. GenMark Diagnostics, Inc.
23.4.10.1. Overview
23.4.10.2. Product Portfolio
23.4.10.3. Profitability by Market Segments (Product/Channel/Region)
23.4.10.4. Sales Footprint
23.4.10.5. Strategy Overview
23.4.10.5.1. Marketing Strategy
23.4.10.5.2. Product Strategy
23.4.10.5.3. Channel Strategy
23.4.11. Qiagen N.V.
23.4.11.1. Overview
23.4.11.2. Product Portfolio
23.4.11.3. Profitability by Market Segments (Product/Channel/Region)
23.4.11.4. Sales Footprint
23.4.11.5. Strategy Overview
23.4.11.5.1. Marketing Strategy
23.4.11.5.2. Product Strategy
23.4.11.5.3. Channel Strategy
23.4.12. Genomix Biotech
23.4.12.1. Overview
23.4.12.2. Product Portfolio
23.4.12.3. Profitability by Market Segments (Product/Channel/Region)
23.4.12.4. Sales Footprint
23.4.12.5. Strategy Overview
23.4.12.5.1. Marketing Strategy
23.4.12.5.2. Product Strategy
23.4.12.5.3. Channel Strategy
23.4.13. bioTheranostics
23.4.13.1. Overview
23.4.13.2. Product Portfolio
23.4.13.3. Profitability by Market Segments (Product/Channel/Region)
23.4.13.4. Sales Footprint
23.4.13.5. Strategy Overview
23.4.13.5.1. Marketing Strategy
23.4.13.5.2. Product Strategy
23.4.13.5.3. Channel Strategy
24. Assumptions and Acronyms Used
25. Research Methodology
Table 1: Global Molecular Diagnostics in Infectious Disease Testing Market Value (US$ Mn) Forecast, By Product, 2017–2032Table 2: Global Molecular Diagnostics in Infectious Disease Testing Market Volume (‘000 Units) Forecast, By Product, 2017–2032
Table 3: Global Molecular Diagnostics in Infectious Disease Testing Market Value (US$ Mn) Forecast, By End User, 2017–2032
Table 4: Global Molecular Diagnostics in Infectious Disease Testing Market Volume (‘000 Units) Forecast, By End User, 2017–2032
Table 5: Global Molecular Diagnostics in Infectious Disease Testing Market Value (US$ Mn) Forecast, By Application, 2017–2032
Table 6: Global Molecular Diagnostics in Infectious Disease Testing Market Volume (‘000 Units) Forecast, By Application, 2017–2032
Table 7: Global Molecular Diagnostics in Infectious Disease Testing Market Value (US$ Mn) Forecast, By Technique, 2017–2032
Table 8: Global Molecular Diagnostics in Infectious Disease Testing Market Volume (‘000 Units) Forecast, By Technique, 2017–2032
Table 9: Global Molecular Diagnostics in Infectious Disease Testing Market Value (US$ Mn) Forecast, By Region, 2017–2032
Table 10: Global Molecular Diagnostics in Infectious Disease Testing Market Volume (‘000 Units) Forecast, By Region, 2017–2032
Table 11: North America Molecular Diagnostics in Infectious Disease Testing Market Value (US$ Mn) Forecast, By Country, 2017–2032
Table 12: North America Molecular Diagnostics in Infectious Disease Testing Market Volume (‘000 Units) Forecast, By Country, 2017–2032
Table 13: North America Molecular Diagnostics in Infectious Disease Testing Market Value (US$ Mn) Forecast, By Product, 2017–2032
Table 14: North America Molecular Diagnostics in Infectious Disease Testing Market Volume (‘000 Units) Forecast, By Product, 2017–2032
Table 15: North America Molecular Diagnostics in Infectious Disease Testing Market Value (US$ Mn) Forecast, By End User, 2017–2032
Table 16: North America Molecular Diagnostics in Infectious Disease Testing Market Volume (‘000 Units) Forecast, By End User, 2017–2032
Table 17: North America Molecular Diagnostics in Infectious Disease Testing Market Value (US$ Mn) Forecast, By Application, 2017–2032
Table 18: North America Molecular Diagnostics in Infectious Disease Testing Market Volume (‘000 Units) Forecast, By Application, 2017–2032
Table 19: North America Molecular Diagnostics in Infectious Disease Testing Market Value (US$ Mn) Forecast, By Technique, 2017–2032
Table 20: North America Molecular Diagnostics in Infectious Disease Testing Market Volume (‘000 Units) Forecast, By Technique, 2017–2032
Table 21: Latin America Molecular Diagnostics in Infectious Disease Testing Market Value (US$ Mn) Forecast, By Country, 2017–2032
Table 22: Latin America Molecular Diagnostics in Infectious Disease Testing Market Volume (‘000 Units) Forecast, By Country, 2017–2032
Table 23: Latin America Molecular Diagnostics in Infectious Disease Testing Market Value (US$ Mn) Forecast, By Product, 2017–2032
Table 24: Latin America Molecular Diagnostics in Infectious Disease Testing Market Volume (‘000 Units) Forecast, By Product, 2017–2032
Table 25: Latin America Molecular Diagnostics in Infectious Disease Testing Market Value (US$ Mn) Forecast, By End User, 2017–2032
Table 26: Latin America Molecular Diagnostics in Infectious Disease Testing Market Volume (‘000 Units) Forecast, By End User, 2017–2032
Table 27: Latin America Molecular Diagnostics in Infectious Disease Testing Market Value (US$ Mn) Forecast, By Application, 2017–2032
Table 28: Latin America Molecular Diagnostics in Infectious Disease Testing Market Volume (‘000 Units) Forecast, By Application, 2017–2032
Table 29: Latin America Molecular Diagnostics in Infectious Disease Testing Market Value (US$ Mn) Forecast, By Technique, 2017–2032
Table 30: Latin America Molecular Diagnostics in Infectious Disease Testing Market Volume (‘000 Units) Forecast, By Technique, 2017–2032
Table 31: Europe Molecular Diagnostics in Infectious Disease Testing Market Value (US$ Mn) Forecast, By Country, 2017–2032
Table 32: Europe Molecular Diagnostics in Infectious Disease Testing Market Volume (‘000 Units) Forecast, By Country, 2017–2032
Table 33: Europe Molecular Diagnostics in Infectious Disease Testing Market Value (US$ Mn) Forecast, By Product, 2017–2032
Table 34: Europe Molecular Diagnostics in Infectious Disease Testing Market Volume (‘000 Units) Forecast, By Product, 2017–2032
Table 35: Europe Molecular Diagnostics in Infectious Disease Testing Market Value (US$ Mn) Forecast, By End User, 2017–2032
Table 36: Europe Molecular Diagnostics in Infectious Disease Testing Market Volume (‘000 Units) Forecast, By End User, 2017–2032
Table 37: Europe Molecular Diagnostics in Infectious Disease Testing Market Value (US$ Mn) Forecast, By Application, 2017–2032
Table 38: Europe Molecular Diagnostics in Infectious Disease Testing Market Volume (‘000 Units) Forecast, By Application, 2017–2032
Table 39: Europe Molecular Diagnostics in Infectious Disease Testing Market Value (US$ Mn) Forecast, By Technique, 2017–2032
Table 40: Europe Molecular Diagnostics in Infectious Disease Testing Market Volume (‘000 Units) Forecast, By Technique, 2017–2032
Table 41: East Asia Molecular Diagnostics in Infectious Disease Testing Market Value (US$ Mn) Forecast, By Country, 2017–2032
Table 42: East Asia Molecular Diagnostics in Infectious Disease Testing Market Volume (‘000 Units) Forecast, By Country, 2017–2032
Table 43: East Asia Molecular Diagnostics in Infectious Disease Testing Market Value (US$ Mn) Forecast, By Product, 2017–2032
Table 44: East Asia Molecular Diagnostics in Infectious Disease Testing Market Volume (‘000 Units) Forecast, By Product, 2017–2032
Table 45: East Asia Molecular Diagnostics in Infectious Disease Testing Market Value (US$ Mn) Forecast, By End User, 2017–2032
Table 46: East Asia Molecular Diagnostics in Infectious Disease Testing Market Volume (‘000 Units) Forecast, By End User, 2017–2032
Table 47: East Asia Molecular Diagnostics in Infectious Disease Testing Market Value (US$ Mn) Forecast, By Application, 2017–2032
Table 48: East Asia Molecular Diagnostics in Infectious Disease Testing Market Volume (‘000 Units) Forecast, By Application, 2017–2032
Table 49: East Asia Molecular Diagnostics in Infectious Disease Testing Market Value (US$ Mn) Forecast, By Technique, 2017–2032
Table 50: East Asia Molecular Diagnostics in Infectious Disease Testing Market Volume (‘000 Units) Forecast, By Technique, 2017–2032
Table 51: South Asia Molecular Diagnostics in Infectious Disease Testing Market Value (US$ Mn) Forecast, By Country, 2017–2032
Table 52: South Asia Molecular Diagnostics in Infectious Disease Testing Market Volume (‘000 Units) Forecast, By Country, 2017–2032
Table 53: South Asia Molecular Diagnostics in Infectious Disease Testing Market Value (US$ Mn) Forecast, By Product, 2017–2032
Table 54: South Asia Molecular Diagnostics in Infectious Disease Testing Market Volume (‘000 Units) Forecast, By Product, 2017–2032
Table 55: South Asia Molecular Diagnostics in Infectious Disease Testing Market Value (US$ Mn) Forecast, By End User, 2017–2032
Table 56: South Asia Molecular Diagnostics in Infectious Disease Testing Market Volume (‘000 Units) Forecast, By End User, 2017–2032
Table 57: South Asia Molecular Diagnostics in Infectious Disease Testing Market Value (US$ Mn) Forecast, By Application, 2017–2032
Table 58: South Asia Molecular Diagnostics in Infectious Disease Testing Market Volume (‘000 Units) Forecast, By Application, 2017–2032
Table 59: South Asia Molecular Diagnostics in Infectious Disease Testing Market Value (US$ Mn) Forecast, By Technique, 2017–2032
Table 60: South Asia Molecular Diagnostics in Infectious Disease Testing Market Volume (‘000 Units) Forecast, By Technique, 2017–2032
Table 61: Oceania Molecular Diagnostics in Infectious Disease Testing Market Value (US$ Mn) Forecast, By Country, 2017–2032
Table 62: Oceania Molecular Diagnostics in Infectious Disease Testing Market Volume (‘000 Units) Forecast, By Country, 2017–2032
Table 63: Oceania Molecular Diagnostics in Infectious Disease Testing Market Value (US$ Mn) Forecast, By Product, 2017–2032
Table 64: Oceania Molecular Diagnostics in Infectious Disease Testing Market Volume (‘000 Units) Forecast, By Product, 2017–2032
Table 65: Oceania Molecular Diagnostics in Infectious Disease Testing Market Value (US$ Mn) Forecast, By End User, 2017–2032
Table 66: Oceania Molecular Diagnostics in Infectious Disease Testing Market Volume (‘000 Units) Forecast, By End User, 2017–2032
Table 67: Oceania Molecular Diagnostics in Infectious Disease Testing Market Value (US$ Mn) Forecast, By Application, 2017–2032
Table 68: Oceania Molecular Diagnostics in Infectious Disease Testing Market Volume (‘000 Units) Forecast, By Application, 2017–2032
Table 69: Oceania Molecular Diagnostics in Infectious Disease Testing Market Value (US$ Mn) Forecast, By Technique, 2017–2032
Table 70: Oceania Molecular Diagnostics in Infectious Disease Testing Market Volume (‘000 Units) Forecast, By Technique, 2017–2032
Table 71: MEA Molecular Diagnostics in Infectious Disease Testing Market Value (US$ Mn) Forecast, By Country, 2017–2032
Table 72: MEA Molecular Diagnostics in Infectious Disease Testing Market Volume (‘000 Units) Forecast, By Country, 2017–2032
Table 73: MEA Molecular Diagnostics in Infectious Disease Testing Market Value (US$ Mn) Forecast, By Product, 2017–2032
Table 74: MEA Molecular Diagnostics in Infectious Disease Testing Market Volume (‘000 Units) Forecast, By Product, 2017–2032
Table 75: MEA Molecular Diagnostics in Infectious Disease Testing Market Value (US$ Mn) Forecast, By End User, 2017–2032
Table 76: MEA Molecular Diagnostics in Infectious Disease Testing Market Volume (‘000 Units) Forecast, By End User, 2017–2032
Table 77: MEA Molecular Diagnostics in Infectious Disease Testing Market Value (US$ Mn) Forecast, By Application, 2017–2032
Table 78: MEA Molecular Diagnostics in Infectious Disease Testing Market Volume (‘000 Units) Forecast, By Application, 2017–2032
Table 79: MEA Molecular Diagnostics in Infectious Disease Testing Market Value (US$ Mn) Forecast, By Technique, 2017–2032
Table 80: MEA Molecular Diagnostics in Infectious Disease Testing Market Volume (‘000 Units) Forecast, By Technique, 2017–2032